Chart calendar Novartis AG

3152.g7ik7H0X2iqPGEJCWtZ25zMO13qxiNcz7yPijovD_KM.-vHS2hJgvmHZXwFyCKEb1mRGrzL8zeRpvhKz9MiyuvTP_eLdCliuXt5iGw~57e0ad78ff62acfb91bf7663be23df26

Upcoming events on Novartis AG

04/02/2026

Q4 2025 Earnings Release

04/02/2026

Q4 2025 Earnings Call

03/03/2026

TD Cowen Healthcare Conference

04/03/2026

UBS European Healthcare Conference

06/03/2026

Annual General Meeting

10/03/2026

Barclays Global Healthcare Conference

24/03/2026

BNP Paribas Exane Healthcare Conference

28/04/2026

Q1 2026 Earnings Release (Projected)

21/07/2026

Q2 2026 Earnings Release (Projected)

03/11/2026

Q3 2026 Earnings Release (Projected)

03/02/2027

Q4 2026 Earnings Release (Projected)

Past events on Novartis AG

12/01/2026

J.P. Morgan Healthcare Conference

12/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-08

12/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS3-09-15

12/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS3-08-27

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PD5-10

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS1-04-17

11/12/2025

San Antonio Breast Cancer Symposium - Abstract No - # PS1-10-27

09/12/2025

American Society of Hematology Meeting - Abstract No - #LBA-2

09/12/2025

American Society of Hematology Meeting - Abstract No - #4981

09/12/2025

American Society of Hematology Meeting - Abstract No - #4978

09/12/2025

American Society of Hematology Meeting - Abstract No - #5549

09/12/2025

American Society of Hematology Meeting - Abstract No - #906

09/12/2025

American Society of Hematology Meeting - Abstract No - #910

09/12/2025

American Society of Hematology Meeting - Abstract No - #844

08/12/2025

American Society of Hematology Meeting - Abstract No - #3198

08/12/2025

American Society of Hematology Meeting - Abstract No - #670

08/12/2025

American Society of Hematology Meeting - Abstract No - #724

07/12/2025

American Society of Hematology Meeting - Abstract No - #1997

04/12/2025

Berenberg European Conference

04/12/2025

Citi Global Healthcare Conference

Past dividends on Novartis AG

11/03/2025

Annual 3.5 CHF

07/03/2024

Annual 3.3 CHF

09/03/2023

Annual 3.2 CHF

08/03/2022

Annual 3.1 CHF

04/03/2021

Annual 3 CHF

03/03/2020

Annual 2.95 CHF

04/03/2019

Annual 2.85 CHF

06/03/2018

Annual 2.8 CHF

02/03/2017

Annual 2.75 CHF

25/02/2016

Annual 2.7 CHF

03/03/2015

2.6 CHF

27/02/2014

Annual 2.45 CHF

26/02/2013

Annual 2.3 CHF

27/02/2012

Annual 2.25 CHF

24/02/2011

Annual 2.2 CHF

02/03/2010

Annual 2.1 CHF

27/02/2009

Annual 2 CHF

29/02/2008

Annual 1.6 CHF

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
50 545
51 352
-1.57%
46 660
46 810
-0.32%
51 722
50 407
2.61%

55 605


57 020


59 367

EBITDA
Million USD
Released
Forecast
Spread
18 613
17 036
9.25%
17 937
18 223
-1.57%
21 006
19 819
5.99%

23 727


23 638


25 010

EBIT
Million USD
Released
Forecast
Spread
16 665
16 417
1.51%
16 372
16 735
-2.17%
19 494
18 983
2.69%

21 845


21 884


23 209

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
8 371
10 562
-20.74%
9 123
10 323
-11.63%
13 640
13 560
0.59%

17 360


17 807


19 047

Net income
Million USD
Released
Forecast
Spread
6 955
8 563
-18.78%
14 854
10 329
43.8%
11 939
11 438
4.38%

14 214


14 247


15 577

EPS
USD
Released
Forecast
Spread
3,19
4,06
-21.46%
7,15
5,38
32.95%
5,92
5,53
7%

7,16


7,40


8,07

Announcement Date01/02/2331/01/2431/01/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
12 120
11 498
5.41%
12 872
12 319
4.49%
13 172
12 666
4%
13 558
12 823
5.73%
13 620
13 116
3.85%
14 836
14 136
4.95%
14 358
13 866
3.55%

13 805


13 723


14 162


14 335


14 110

EBITDA
Million USD
Released
Forecast
Spread









5 294












4 861













EBIT
Million USD
Released
Forecast
Spread
4 537
4 220
7.52%
4 953
4 667
6.12%
5 145
4 892
5.16%
4 859
4 435
9.56%
5 575
5 272
5.75%
5 925
5 827
1.68%
5 460
5 520
-1.08%

4 853


5 604


5 552


5 371


4 807

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
3 129
3 453
-9.38%
3 841
3 896
-1.41%
3 385
4 028
-15.96%
3 285
3 478
-5.55%






4 196
4 238
-0.99%















Net income
Million USD
Released
Forecast
Spread
2 688
2 459
9.31%
3 246
2 858
13.59%
3 189
3 197
-0.25%
2 820
2 585
9.08%
3 606
3 255
10.78%
4 024
3 909
2.93%
3 930
3 652
7.61%

2 414


3 350


3 690


3 590


3 381

EPS
USD
Released
Forecast
Spread
1,31
1,19
10.18%
1,60
1,40
14.13%
1,58
1,48
7.03%
1,42
1,30
9.63%
1,83
1,65
10.96%
2,07
1,99
3.77%
2,04
1,87
9.02%

1,26


1,75


1,93


1,87


1,77

Announcement Date23/04/2418/07/2429/10/2431/01/2529/04/2517/07/2528/10/25-----
23/01/2026

Q3 2026 Earnings Release

23/01/2026

Q3 2026 Earnings Release

28/01/2026

Q3 2026 Earnings Release

28/01/2026

Q3 2025 Earnings Release

28/01/2026

Q3 2026 Earnings Release

28/01/2026

Q3 2026 Earnings Release (Projected)

28/01/2026

Q4 2025 Earnings Release

29/01/2026

Q4 2025 Earnings Release

29/01/2026

Q4 2025 Earnings Release

29/01/2026

Q3 2025 Earnings Release

More events

Past sector events for Novartis AG

Today

Q3 2026 Earnings Release (Projected)

Today

Q3 2026 Earnings Release

21/01/2026

Q3 2026 Earnings Release

21/01/2026

Q4 2025 Earnings Release

21/01/2026

Q4 2025 Earnings Release

16/01/2026

Q3 2026 Earnings Release

16/01/2026

Q3 2026 Earnings Release (Projected)

12/01/2026

December 2025 Sales and Revenue Release

10/01/2026

December 2025 Sales and Revenue Release

09/01/2026

December 2025 Sales and Revenue Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise